Pfizer expands research capacity with Cambridge, MA location
- Pfizer is expanding its presence in Massachusetts with a new research and development center where academic researchers, hospitals and industry professionals will collaborate on clinical development projects.
- The new advanced-science laboratory facilities are being leased from MIT and are located in Kendall Square in Cambridge.
- The Kendall Square research team is being led by Pfizer’s Group Vice President of Bio Therapeutics R&D, José-Carlos Gutiérrez-Ramos, PhD.
With a research facility in Andover and its global headquarters for the Centers for Therapeutic Innovation (CTI) in Boston, Pfizer has had a presence in Massachusetts for 15 years. However, the new 280,000 square-foot, Kendall Square location will position Pfizer at the epicenter of a productive research hub in which 1,000 R&D professionals will work together.
Areas of therapeutic research will include inflammation, immunology, rare diseases, cardiovascular and metabolic diseases and neuroscience.